Skin Science

Labskin Research Programme 2015

Labskin is currently involved in multiple innovative research programmes with leading researchers in the UK & the US. The product’s unique capabilities to mimic human skin allow researchers to conduct various tests as you can see from the range of projects below.

If you have any queries in relation to Labskin or you are interested in participating in our research programmes, please contact Declan Service – declan.service@innovenn.co.uk.

    • Collaborators:
      Prof. Malcolm Clench & Dr. Amanda Harvey
      (Sheffield Hallam)
    • Expertise:
      Matrix assisted laser desorption ionisation – ion mobility separation – mass spectrometry imaging (MALDI-IMS-MSI)
    • Project:
      Treatment of LabSkin with IL-22 to generate psoriasis model. Characterisation of Labskin structure and function, continuing on from successful POC study

    • Collaborators:
      Dr. Jim McKim (IONTOX – Michigan)
    • Expertise:
      Metabolic and Toxicology profiling by gene panel assays
    • Project:
      Contract research to characterise the metabolic profile of Labskin

    • Collaborators:
      Dr Malcolm J. Horsburgh (University of Liverpool)
    • Expertise:
      Sequencing technologies via genomics and transcriptomics (RNA-seq.) Models for colonisation and survival
    • Project:
      Comparative skin survival of mutants of S.aureus. Determine performance of Labskin in survival assays in order determine the best assay format

    • Collaborators:
      Dr Kevin Hamill (University of Liverpool)
    • Expertise:
      Effects of microenviroment on cell behaviour.
    • Project:
      Looking at wound healing properties in Labskin particularly the reepithialisation of the skin model.

    • Collaborators:
      Dr Nicola Fletcher (University of Birmingham)
    • Expertise:
      Research focuses on understanding the mechanism of hepatitis C virus (HCV) entry into the liver and how the virus persists to evade the innate and adaptive immune responses.
    • Project:
      To assess the ability of LabSkin to support infection with viral pseudotypes – Epstein-Barr Virus (EBV) and Herpes Simplex Virus (HSV).
      To assess the ability of ML:8 to inhibit a HSV infection (in collaboration with Dr. Mike Folan).
Back to Top